stockportfolio.pro
Pacira BioSciences, Inc. Total Debt 2009–2025
Pacira BioSciences, Inc. (PCRX) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $372.19M | -52.7% |
| FY 2024 | $787.10M | +50.7% |
| FY 2023 | $522.44M | -24.2% |
| FY 2022 | $689.47M | — |
| FY 2021 | $0 | — |
| FY 2020 | $0 | — |
| FY 2019 | $0 | — |
| FY 2018 | $0 | — |
| FY 2017 | $0 | -100.0% |
| FY 2016 | $108.74M | +4.5% |
| FY 2015 | $104.04M | +0.9% |
| FY 2014 | $103.10M | +4.2% |
| FY 2013 | $98.96M | +292.8% |
| FY 2012 | $25.19M | -1.5% |
| FY 2011 | $25.58M | +17.0% |
| FY 2010 | $21.87M | — |
| FY 2009 | $0 | — |
Source: Pacira BioSciences, Inc. SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Pacira BioSciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePacira BioSciences, Inc. — frequently asked questions
What is Pacira BioSciences, Inc.'s total debt (short- plus long-term borrowings)?
Pacira BioSciences, Inc. (PCRX) reported total debt (short- plus long-term borrowings) of $372.19M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Pacira BioSciences, Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.